What the instrument is
The Health Insurance (Medicare Benefits Payable in Respect of Professional Services - First Nations Molecular Point-of-Care Testing Program) Direction (No. 1) 2026 is a new federal legislative instrument. It was registered on the Federal Register of Legislation on 20 October 2026 and is currently in force.
The instrument is administered by the Department of Health, Disability and Ageing.
What it covers
Based on its title, the Direction relates to Medicare benefits payable for professional services under a First Nations Molecular Point-of-Care Testing Program. The source page provides only the title, registration details and status of the instrument. It does not include the actual text or operational detail of the Direction, so the specifics of what it changes, who it applies to, or what Medicare benefit arrangements it covers are not specified in this content.
Details such as eligibility, dollar amounts, or compliance obligations are not specified in the available source material.
Key actions
- Health and medical business owners involved in pathology or point-of-care testing for First Nations communities can view the full legislation text at https://www.legislation.gov.au/F2026N00773 to check for details relevant to their service.
- The 'Set up an alert' or 'Save this title to My Account' options on the Federal Register of Legislation page for this instrument can be used to receive notification of any amendments or related updates.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.